Coverage

Michael J. Fox Foundation for Parkinson's Research Honored with Advocacy/Policy Award from Reagan-Udall Foundation for the FDA - PR Newswire
NEW YORK, Dec. 9, 2020 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) has received the Advocacy/Policy Award from the Reagan-Udall Foundation for the Food and Drug Administration. MJFF is the second…
Read More
Surescripts Fireside Chat with Dr. Amy Abernethy, Principal Deputy Commissioner and Acting CIO, FDA
Tom Skelton, CEO of Surescripts, recently spoke with Dr. Amy Abernethy of the FDA, about the impact of COVID-19 and the evolving data needs of public health.    
Read More
We may soon have a COVID-19 vaccine. But will enough people take it? - Reuters
ZURICH/LONDON (Reuters) - With COVID-19 vaccine trial results looking positive, governments and pharmaceutical firms face their next daunting challenge: convincing the world to get inoculated. Public resistance to vaccines has been much discussed this…
Read More
In Brief - The Cancer Letter
Reagan-Udall receives $250,000 from Rockefeller Foundation for COVID-19 Diagnostics Evidence Accelerator
Read More
Officials clarify military role in coronavirus vaccination amid wariness - Roll Call
President Donald Trump has often touted the role of the military in distributing a COVID-19 vaccine, but health officials close to the process who are concerned about public distrust are taking pains to say the federal government won’t actually be…
Read More
Black Americans are the most hesitant to get a COVID-19 vaccine - USA Today
Black Americans distrust the government so much they're not participating in large numbers in COVID-19 clinical trials, and many say they won't get a COVID-19 vaccine – at least not until many others get it. Although the first two large clinical…
Read More
Rushing COVID-19 Vaccination Could Undermine Overall Success, Vaccine Experts Warn FDA - IDSE
Extraordinary and unusual measures may be needed to rapidly develop and distribute a vaccine against SARS-CoV-2, but those efforts should not compromise the safety and efficacy of any product that reaches the market, according to the FDA Vaccines and…
Read More
‘There’s only one chance to do this right’—FDA panel wrestles with COVID-19 vaccine issues - Science
Concerns raised yesterday by an advisory group to the U.S. Food and Drug Administration (FDA) may once again tap the brakes on Operation Warp Speed, the U.S. government’s $10.8 billion push to rapidly move candidate COVID-19 vaccines from concept to…
Read More
Patient Warehousing Emerges As Another COVID-19 Vaccine Confidence Problem - Pink Sheet
Executive Summary CDC officials designing distribution plans worry some eligible for vaccination may wait for a better product to emerge. Federal officials are now confronting another challenge for the uptake of a potential coronavirus vaccine –…
Read More
FDA advisory committee debates safety and efficacy standards for a coronavirus vaccine - The Washington Post
Vaccine experts on Thursday rigorously debated the Food and Drug Administration’s planned standards for clearing a coronavirus vaccine quickly for broad use, discussing what level of evidence would be sufficient to establish safety and…
Read More